# Peter Hersey

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-hersey/

## Facts

| Field | Value |
| --- | --- |
| Citations | 68,143 |
| Field | Immunotherapy and Immune Responses |
| h-index | 107 |
| i10-index | 363 |
| Last Known Institution | The University of Sydney |
| OpenAlex ID | https://openalex.org/A5055038393 |
| ORCID iD | https://orcid.org/0000-0002-3064-737X |
| Works | 638 |

## Researcher papers

- [Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma](https://scholariq.org/papers/completion-dissection-or-observation-for-sentinel-node-metastasis-in-melanoma/)
- [Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial](https://scholariq.org/papers/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma-eortc-1325/)

## Researcher topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [The University of Sydney](https://scholariq.org/institutions/the-university-of-sydney/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.